Bayer Stock Takes Significant Hit After Nearly $300 Million Roundup Cancer Verdict
Bayer's stock has slumped significantly in the aftermath of a historic verdict that saw a California jury award $289 million to a groundskeeper who argued that his terminal cancer was caused by Roundup. On Monday, August 13th, the company's stock slumped more than 10 percent in trading just months after Bayer acquired Monsanto, the company who makes the popular Roundup…